These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 9166533)
1. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225 [TBL] [Abstract][Full Text] [Related]
4. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894 [TBL] [Abstract][Full Text] [Related]
5. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
6. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058 [TBL] [Abstract][Full Text] [Related]
7. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901 [TBL] [Abstract][Full Text] [Related]
10. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Hatfield P; Cooper R; Sebag-Montefiore D Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845 [TBL] [Abstract][Full Text] [Related]
15. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy. Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138 [TBL] [Abstract][Full Text] [Related]
16. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Edelman S; Johnstone PA Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522 [TBL] [Abstract][Full Text] [Related]
17. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Mulayim N; Foster Silver D; Schwartz PE; Higgins S Gynecol Oncol; 2004 Jun; 93(3):659-66. PubMed ID: 15196861 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728 [TBL] [Abstract][Full Text] [Related]
19. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014). Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF; Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599 [TBL] [Abstract][Full Text] [Related]
20. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Crehange G; Bosset M; Lorchel F; Dumas JL; Buffet-Miny J; Puyraveau M; Mercier M; Bosset JF Dis Colon Rectum; 2007 Jan; 50(1):43-9. PubMed ID: 17089083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]